GH

Guardant Health
NASDAQ
17.45
-0.29
-1.63%
Closed 19:57 03/18 EDT
OPEN
17.80
PREV CLOSE
17.74
HIGH
17.97
LOW
17.40
VOLUME
2.15M
TURNOVER
0
52 WEEK HIGH
41.06
52 WEEK LOW
17.40
MARKET CAP
2.12B
P/E (TTM)
-4.0759
1D
5D
1M
3M
1Y
5Y
Analysts’ Top Healthcare Picks: Compass Therapeutics (CMPX), Guardant Health (GH)
TipRanks · 1h ago
Weekly Report: what happened at GH last week (0311-0315)?
Weekly Report · 22h ago
Health Rounds: CAR-T therapy shows early promise against brain cancer
Health Rounds: CAR-T therapy shows early promise against brain cancer. A blood test for detecting colorectal cancer that was as accurate as current commercial home tests. Early trials hint at benefit ofCAR-T cells in glioblastoma. The therapy shrank tumors in three separate early-stage trials.
Reuters · 4d ago
Buy Rating Affirmed for Guardant Health Amid Strong Shield Test Prospects and Positive ECLIPSE Study Results
TipRanks · 4d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Guardant Health (GH), Cue Health (HLTH) and Skye Bioscience (OtherSKYE)
TipRanks · 4d ago
December 2025 Options Now Available For Guardant Health (GH)
NASDAQ · 6d ago
Weekly Report: what happened at GH last week (0304-0308)?
Weekly Report · 03/11 09:27
Weekly Report: what happened at GH last week (0226-0301)?
Weekly Report · 03/04 09:28
More
About GH
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer globally through the use of its proprietary tests, vast data sets and advanced analytics. The Company has developed its Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced-stage cancer. It also has developed Guardant360 TissueNext tissue test for advanced-stage cancer, Guardant Reveal blood test to detect residual and recurring disease in early-stage cancer patients, and Guardant360 Response blood test to predict patient response to immunotherapy or targeted therapy eight weeks earlier than current standard-of-care imaging. The Company’s GuardantINFORM platform is used to help biopharmaceutical companies accelerate precision oncology drug development through the use of this in-silico research platform to unlock further insights into tumor evolution and treatment resistance across various biomarker-driven cancers.

Webull offers Guardant Health Inc stock information, including NASDAQ: GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GH stock methods without spending real money on the virtual paper trading platform.